Sterling Capital Management LLC Summit Therapeutics Inc. Transaction History
Sterling Capital Management LLC
- $7.74 Trillion
- Q3 2024
A detailed history of Sterling Capital Management LLC transactions in Summit Therapeutics Inc. stock. As of the latest transaction made, Sterling Capital Management LLC holds 99 shares of SMMT stock, worth $2,127. This represents 0.0% of its overall portfolio holdings.
Number of Shares
99Holding current value
$2,127% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding SMMT
# of Institutions
173Shares Held
70.4MCall Options Held
1.3MPut Options Held
2.06M-
Baker Bros. Advisors LP New York, NY24.4MShares$525 Million5.73% of portfolio
-
Vanguard Group Inc Valley Forge, PA10.9MShares$235 Million0.0% of portfolio
-
Black Rock Inc. New York, NY7.9MShares$170 Million0.0% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD5.44MShares$117 Million0.01% of portfolio
-
State Street Corp Boston, MA3.47MShares$74.5 Million0.0% of portfolio
About Summit Therapeutics Inc.
- Ticker SMMT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 201,215,008
- Market Cap $4.32B
- Description
- Summit Therapeutics Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines to treat infectious diseases in the United States and Latin America. It conducts clinical programs focusing on Clostridioides difficile infection (CDI). The company's lead product candidate is ridinilazole, an orally administered small molecu...